(NASDAQ: LNTH) Lantheus Holdings's forecast annual revenue growth rate of 8.18% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 7.92%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.48%.
Lantheus Holdings's revenue in 2026 is $1,541,609,000.On average, 15 Wall Street analysts forecast LNTH's revenue for 2026 to be $97,813,323,516, with the lowest LNTH revenue forecast at $90,835,886,964, and the highest LNTH revenue forecast at $108,021,054,768. On average, 14 Wall Street analysts forecast LNTH's revenue for 2027 to be $110,992,925,892, with the lowest LNTH revenue forecast at $100,332,953,382, and the highest LNTH revenue forecast at $126,175,310,982.
In 2028, LNTH is forecast to generate $126,562,946,346 in revenue, with the lowest revenue forecast at $108,085,660,662 and the highest revenue forecast at $149,433,432,822.